Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/OncologyTodayTGCT24" rel="nofollow">here</a>.

<description>Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayTGCT24). 
</description>

Featuring a discussion on the management of tenosynovial giant cell tumor with Dr Emanuela Palmerini, moderated by Dr Neil Love. Produced by Research To Practice.

Optimizing the Management of Tenosynovial Giant Cell Tumor

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/FCS2024" rel="nofollow">here</a>.

<description>Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/FCS2024). 
</description>

Featuring discussions with specialists on optimal management and the potential role of investigational approaches for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/FCS2024" rel="nofollow">here</a>.

<description>Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/FCS2024). 
</description>

Featuring discussions on optimal management and investigational approaches for non-Hodgkin lymphoma and chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. 

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia 

Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Hope S Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center discuss treatment decision-making for HR-positive metastatic breast cancer in patients who harbor PI3K/AKT/PTEN pathway mutations, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/PI3KAKTPTENmBC24" rel="nofollow">here</a>.

<description>Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Hope S Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center discuss treatment decision-making for HR-positive metastatic breast cancer in patients who harbor PI3K/AKT/PTEN pathway mutations, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/PI3KAKTPTENmBC24). 
</description>

Featuring a discussion on the management of HR+ metastatic breast cancer with mutations in PI3K, AKT or PTEN with Drs Jhaveri and Rugo, moderated by Dr Neil Love. Produced by Research To Practice. 

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/FCS2024" rel="nofollow">here</a>.

<description>Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/FCS2024). 
</description>

Featuring discussions with specialists on optimal management and the potential role of investigational approaches for lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.


Hepatocellular Carcinoma Update

Details

Recent Episodes